Xencor (XNCR) Non Operating Investment Income (2015 - 2026)

Xencor's (XNCR) quarterly Non Operating Investment Income came in at -$51.9 million in Q1 2026, down 5618.49% year-on-year from $941000.0 in Q1 2025, and down 201.02% on a QoQ basis from $51.4 million in Q4 2025.

Xencor (XNCR) Non Operating Investment Income (2015 - 2026) Analysis & Trends

Xencor (XNCR) has 12 years of Non Operating Investment Income data on file, last reported at -$51.9 million in Q1 2026.

  • On a quarterly basis, Non Operating Investment Income fell 5618.49% year-over-year to -$51.9 million in Q1 2026; TTM through Mar 2026 was $48.6 million, a 248.28% increase from a year earlier, with the FY2025 full-year figure at $101.5 million, up 423.07% from the prior year.
  • Non Operating Investment Income for Q1 2026 stood at -$51.9 million, down from $51.4 million in the prior quarter.
  • Over the last five years, Non Operating Investment Income for XNCR reached as high as $51.4 million in Q4 2025 and fell as low as -$51.9 million in Q1 2026.
  • Historically, Non Operating Investment Income has averaged $3.8 million across 5 years, with a median of $2.3 million in 2024.
  • Across the five-year window, Non Operating Investment Income plunged 15008.7% in 2022 and surged 671.17% in 2024, its largest moves.
  • Year by year, Non Operating Investment Income stood at $31.8 million in 2022, then sank by 58.37% to $13.2 million in 2023, then slumped by 333.98% to -$31.0 million in 2024, then soared by 265.96% to $51.4 million in 2025, then sank by 201.02% to -$51.9 million in 2026.
  • Per Business Quant data, the three most recent Non Operating Investment Income figures were -$51.9 million in Q1 2026, $51.4 million in Q4 2025, and $44.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Investment Income (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn -
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - -
10 Xencor 1.47 Bn 1.09 Bn - -51.93 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -51.93 Mn
Mar 31, 2026 -51.93 Mn
Dec 31, 2025 51.41 Mn
Dec 31, 2025 51.41 Mn
Sep 30, 2025 44.20 Mn
Sep 30, 2025 44.20 Mn
Jun 30, 2025 4.97 Mn
Jun 30, 2025 4.97 Mn
Mar 31, 2025 941,000.00
Mar 31, 2025 941,000.00
Dec 31, 2024 -30.97 Mn
Dec 31, 2024 -30.97 Mn
Sep 30, 2024 9.25 Mn
Sep 30, 2024 9.25 Mn
Jun 30, 2024 -12.03 Mn
Jun 30, 2024 -12.03 Mn
Mar 31, 2024 2.33 Mn
Mar 31, 2024 2.33 Mn
Dec 31, 2023 13.24 Mn
Dec 31, 2023 13.24 Mn